Formulation Development

In-depth knowledge of the strengths and weaknesses of your API is fundamental to the long-term success of your product. Solid State Chemistry and pre formulation studies paint a clearer picture of what drug candidate you should chose early on, optimization opportunities, or any obstacles that will need to be overcome moving forward. At Nuwill, our advanced analysis techniques, solid state chemistry and pre formulation testing services can often result in manufacturing efficiency, reduced costs and improved timelines.

Using state-of-the-art technologies, we are able to rapidly capture all relevant information with minimal drug substance per experiment. This means that we can support all of your screening needs, no matter what stage of the drug development process you are in.

Through Nuwill’s extensive capabilities we can:

  • Determine the compound’s physical and chemical characteristics
  • Identify the best form of drug substance and excipients to use in dosage form development
  • Generate data that are a prerequisite to dosage form developmentLiposomal products

Selecting the right compound to move forward is a critical step to a successful drug development campaign. Nuwill helps clients develop assess their drug candidate’s solid state and physicochemical characteristics. A deep understanding of each provides a better decision on the best compound to take into the clinic as well as secure intellectual property protection.

The Nuwill Advantage

Nuwill has the expertise and knowledge to ensure a successful formulation development path, leading you to a more robust drug development campaign. We have maximized our analytical capabilities to help our clients avoid any future pitfalls.

Nuwill has a broad knowledge and technical experience in dosage form development and stability studies

Nuwill is able to provide clients with a wide range of options to develop small molecules into quality pharmaceutical products. The key to our success is being able to provide a flexible and quality driven approach to the client whether it is a step-by-step approach to development work or the transfer of a product into development at late stage. Nuwill’s highly trained scientific team has extensive experience working with a variety of drug substances with a range of physicochemical characteristics, including:

  • Poorly aqueous soluble drugs
  • Highly potent drugs
  • Liposomal products

Nuwill will thoughtfully work with you to determine the most efficient and viable pathway for your compound. Nuwill’s development capabilities include modified and extended release formulations. For poorly soluble compounds, Nuwill offers a variety of bioavailability enhancement technologies.

Formulation Development Services:

  • Literature & Patent search
  • API/ Raw material / Packaging material sourcing
  • RLD characterization
  • Pre - formulation studies
  • Development studies
  • Dissolution Profile matching
  • Lab scale development studies
  • QBD trials
  • Scale up batches/ Tech transfer at 3rd party site
  • Exhibit batches at 3rd party site as per client’s request
  • Product Development Report

Formulation Development Study Capabilities

Dosage Forms: For US, EU and ROW

  • Hard Gelatin Controlled/ Delayed Release Capsules
  • Liquid Formulations
  • (Suspensions/ Syrups/ Solutions)

  • Ointments/ Creams/ Gels
  • Sterile Injectable Products
  • Ear / Eye Drops
  • Para IV filing
The key to our success is being able to provide a flexible and quality driven approach to the clients our advanced analysis techniques, solid state chemistry and pre formulation testing services can often result in manufacturing efficiency, reduced costs and improved timelines.
+91 96639 19615 / 99728 31500
info@nuwillresearch.com